Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radic...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Hahn, Noah M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex - Siero, Jeroen C.W. ELSEVIER, 2014transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:34 ; year:2016 ; number:1 ; pages:411-417 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.urolonc.2015.08.005 |
|---|
| Katalog-ID: |
ELV02997285X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV02997285X | ||
| 003 | DE-627 | ||
| 005 | 20230623203242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.urolonc.2015.08.005 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016018000010.pica |
| 035 | |a (DE-627)ELV02997285X | ||
| 035 | |a (ELSEVIER)S1078-1439(15)00402-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Hahn, Noah M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| 264 | 1 | |c 2016 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). | ||
| 650 | 7 | |a Src-family kinases |2 Elsevier | |
| 650 | 7 | |a Neoadjuvant therapy |2 Elsevier | |
| 650 | 7 | |a Dasatinib |2 Elsevier | |
| 650 | 7 | |a Translational medical research |2 Elsevier | |
| 650 | 7 | |a Bladder |2 Elsevier | |
| 650 | 7 | |a Urothelial carcinoma |2 Elsevier | |
| 650 | 7 | |a Protein kinase inhibitors |2 Elsevier | |
| 700 | 1 | |a Knudsen, Beatrice S. |4 oth | |
| 700 | 1 | |a Daneshmand, Siamak |4 oth | |
| 700 | 1 | |a Koch, Michael O. |4 oth | |
| 700 | 1 | |a Bihrle, Richard |4 oth | |
| 700 | 1 | |a Foster, Richard S. |4 oth | |
| 700 | 1 | |a Gardner, Thomas A. |4 oth | |
| 700 | 1 | |a Cheng, Liang |4 oth | |
| 700 | 1 | |a Liu, Ziyue |4 oth | |
| 700 | 1 | |a Breen, Timothy |4 oth | |
| 700 | 1 | |a Fleming, Mark T. |4 oth | |
| 700 | 1 | |a Lance, Raymond |4 oth | |
| 700 | 1 | |a Corless, Christopher L. |4 oth | |
| 700 | 1 | |a Alva, Ajjai S. |4 oth | |
| 700 | 1 | |a Shen, Steven S. |4 oth | |
| 700 | 1 | |a Huang, Fangjin |4 oth | |
| 700 | 1 | |a Gertych, Arkadiusz |4 oth | |
| 700 | 1 | |a Gallick, Gary E. |4 oth | |
| 700 | 1 | |a Mallick, Jayati |4 oth | |
| 700 | 1 | |a Ryan, Christopher |4 oth | |
| 700 | 1 | |a Galsky, Matthew D. |4 oth | |
| 700 | 1 | |a Lerner, Seth P. |4 oth | |
| 700 | 1 | |a Posadas, Edwin M. |4 oth | |
| 700 | 1 | |a Sonpavde, Guru |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Siero, Jeroen C.W. ELSEVIER |t BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |d 2014transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV012523860 |
| 773 | 1 | 8 | |g volume:34 |g year:2016 |g number:1 |g pages:411-417 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.urolonc.2015.08.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2016 |e 1 |h 411-417 |g 7 |y 34.2016, 1, 4.e11-, (7 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
n m h nm nmh |
|---|---|
| matchkey_str |
hahnnoahmknudsenbeatricesdaneshmandsiama:2016----:eajvndstnbomslivsvbadracrihisen |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.urolonc.2015.08.005 doi GBVA2016018000010.pica (DE-627)ELV02997285X (ELSEVIER)S1078-1439(15)00402-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Hahn, Noah M. verfasserin aut Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Elsevier Knudsen, Beatrice S. oth Daneshmand, Siamak oth Koch, Michael O. oth Bihrle, Richard oth Foster, Richard S. oth Gardner, Thomas A. oth Cheng, Liang oth Liu, Ziyue oth Breen, Timothy oth Fleming, Mark T. oth Lance, Raymond oth Corless, Christopher L. oth Alva, Ajjai S. oth Shen, Steven S. oth Huang, Fangjin oth Gertych, Arkadiusz oth Gallick, Gary E. oth Mallick, Jayati oth Ryan, Christopher oth Galsky, Matthew D. oth Lerner, Seth P. oth Posadas, Edwin M. oth Sonpavde, Guru oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:1 pages:411-417 extent:7 https://doi.org/10.1016/j.urolonc.2015.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 1 411-417 7 34.2016, 1, 4.e11-, (7 S.) 045F 610 |
| spelling |
10.1016/j.urolonc.2015.08.005 doi GBVA2016018000010.pica (DE-627)ELV02997285X (ELSEVIER)S1078-1439(15)00402-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Hahn, Noah M. verfasserin aut Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Elsevier Knudsen, Beatrice S. oth Daneshmand, Siamak oth Koch, Michael O. oth Bihrle, Richard oth Foster, Richard S. oth Gardner, Thomas A. oth Cheng, Liang oth Liu, Ziyue oth Breen, Timothy oth Fleming, Mark T. oth Lance, Raymond oth Corless, Christopher L. oth Alva, Ajjai S. oth Shen, Steven S. oth Huang, Fangjin oth Gertych, Arkadiusz oth Gallick, Gary E. oth Mallick, Jayati oth Ryan, Christopher oth Galsky, Matthew D. oth Lerner, Seth P. oth Posadas, Edwin M. oth Sonpavde, Guru oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:1 pages:411-417 extent:7 https://doi.org/10.1016/j.urolonc.2015.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 1 411-417 7 34.2016, 1, 4.e11-, (7 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.urolonc.2015.08.005 doi GBVA2016018000010.pica (DE-627)ELV02997285X (ELSEVIER)S1078-1439(15)00402-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Hahn, Noah M. verfasserin aut Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Elsevier Knudsen, Beatrice S. oth Daneshmand, Siamak oth Koch, Michael O. oth Bihrle, Richard oth Foster, Richard S. oth Gardner, Thomas A. oth Cheng, Liang oth Liu, Ziyue oth Breen, Timothy oth Fleming, Mark T. oth Lance, Raymond oth Corless, Christopher L. oth Alva, Ajjai S. oth Shen, Steven S. oth Huang, Fangjin oth Gertych, Arkadiusz oth Gallick, Gary E. oth Mallick, Jayati oth Ryan, Christopher oth Galsky, Matthew D. oth Lerner, Seth P. oth Posadas, Edwin M. oth Sonpavde, Guru oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:1 pages:411-417 extent:7 https://doi.org/10.1016/j.urolonc.2015.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 1 411-417 7 34.2016, 1, 4.e11-, (7 S.) 045F 610 |
| allfieldsGer |
10.1016/j.urolonc.2015.08.005 doi GBVA2016018000010.pica (DE-627)ELV02997285X (ELSEVIER)S1078-1439(15)00402-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Hahn, Noah M. verfasserin aut Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Elsevier Knudsen, Beatrice S. oth Daneshmand, Siamak oth Koch, Michael O. oth Bihrle, Richard oth Foster, Richard S. oth Gardner, Thomas A. oth Cheng, Liang oth Liu, Ziyue oth Breen, Timothy oth Fleming, Mark T. oth Lance, Raymond oth Corless, Christopher L. oth Alva, Ajjai S. oth Shen, Steven S. oth Huang, Fangjin oth Gertych, Arkadiusz oth Gallick, Gary E. oth Mallick, Jayati oth Ryan, Christopher oth Galsky, Matthew D. oth Lerner, Seth P. oth Posadas, Edwin M. oth Sonpavde, Guru oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:1 pages:411-417 extent:7 https://doi.org/10.1016/j.urolonc.2015.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 1 411-417 7 34.2016, 1, 4.e11-, (7 S.) 045F 610 |
| allfieldsSound |
10.1016/j.urolonc.2015.08.005 doi GBVA2016018000010.pica (DE-627)ELV02997285X (ELSEVIER)S1078-1439(15)00402-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Hahn, Noah M. verfasserin aut Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Elsevier Knudsen, Beatrice S. oth Daneshmand, Siamak oth Koch, Michael O. oth Bihrle, Richard oth Foster, Richard S. oth Gardner, Thomas A. oth Cheng, Liang oth Liu, Ziyue oth Breen, Timothy oth Fleming, Mark T. oth Lance, Raymond oth Corless, Christopher L. oth Alva, Ajjai S. oth Shen, Steven S. oth Huang, Fangjin oth Gertych, Arkadiusz oth Gallick, Gary E. oth Mallick, Jayati oth Ryan, Christopher oth Galsky, Matthew D. oth Lerner, Seth P. oth Posadas, Edwin M. oth Sonpavde, Guru oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:1 pages:411-417 extent:7 https://doi.org/10.1016/j.urolonc.2015.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 1 411-417 7 34.2016, 1, 4.e11-, (7 S.) 045F 610 |
| language |
English |
| source |
Enthalten in BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex Amsterdam [u.a.] volume:34 year:2016 number:1 pages:411-417 extent:7 |
| sourceStr |
Enthalten in BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex Amsterdam [u.a.] volume:34 year:2016 number:1 pages:411-417 extent:7 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Src-family kinases Neoadjuvant therapy Dasatinib Translational medical research Bladder Urothelial carcinoma Protein kinase inhibitors |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| authorswithroles_txt_mv |
Hahn, Noah M. @@aut@@ Knudsen, Beatrice S. @@oth@@ Daneshmand, Siamak @@oth@@ Koch, Michael O. @@oth@@ Bihrle, Richard @@oth@@ Foster, Richard S. @@oth@@ Gardner, Thomas A. @@oth@@ Cheng, Liang @@oth@@ Liu, Ziyue @@oth@@ Breen, Timothy @@oth@@ Fleming, Mark T. @@oth@@ Lance, Raymond @@oth@@ Corless, Christopher L. @@oth@@ Alva, Ajjai S. @@oth@@ Shen, Steven S. @@oth@@ Huang, Fangjin @@oth@@ Gertych, Arkadiusz @@oth@@ Gallick, Gary E. @@oth@@ Mallick, Jayati @@oth@@ Ryan, Christopher @@oth@@ Galsky, Matthew D. @@oth@@ Lerner, Seth P. @@oth@@ Posadas, Edwin M. @@oth@@ Sonpavde, Guru @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012523860 |
| dewey-sort |
3610 |
| id |
ELV02997285X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02997285X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623203242.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.urolonc.2015.08.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02997285X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1078-1439(15)00402-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hahn, Noah M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Src-family kinases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neoadjuvant therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dasatinib</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Translational medical research</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bladder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelial carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Protein kinase inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Knudsen, Beatrice S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Daneshmand, Siamak</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koch, Michael O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bihrle, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Foster, Richard S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gardner, Thomas A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cheng, Liang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Ziyue</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Breen, Timothy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fleming, Mark T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lance, Raymond</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Corless, Christopher L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alva, Ajjai S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shen, Steven S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Fangjin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gertych, Arkadiusz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gallick, Gary E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mallick, Jayati</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ryan, Christopher</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galsky, Matthew D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lerner, Seth P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Posadas, Edwin M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sonpavde, Guru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Siero, Jeroen C.W. ELSEVIER</subfield><subfield code="t">BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex</subfield><subfield code="d">2014transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012523860</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:34</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:411-417</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.urolonc.2015.08.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">34</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">411-417</subfield><subfield code="g">7</subfield><subfield code="y">34.2016, 1, 4.e11-, (7 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Hahn, Noah M. |
| spellingShingle |
Hahn, Noah M. ddc 610 Elsevier Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| authorStr |
Hahn, Noah M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012523860 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors Elsevier |
| topic |
ddc 610 Elsevier Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors |
| topic_unstemmed |
ddc 610 Elsevier Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors |
| topic_browse |
ddc 610 Elsevier Src-family kinases Elsevier Neoadjuvant therapy Elsevier Dasatinib Elsevier Translational medical research Elsevier Bladder Elsevier Urothelial carcinoma Elsevier Protein kinase inhibitors |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b s k bs bsk s d sd m o k mo mok r b rb r s f rs rsf t a g ta tag l c lc z l zl t b tb m t f mt mtf r l rl c l c cl clc a s a as asa s s s ss sss f h fh a g ag g e g ge geg j m jm c r cr m d g md mdg s p l sp spl e m p em emp g s gs |
| hierarchy_parent_title |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| hierarchy_parent_id |
ELV012523860 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012523860 |
| title |
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| ctrlnum |
(DE-627)ELV02997285X (ELSEVIER)S1078-1439(15)00402-0 |
| title_full |
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| author_sort |
Hahn, Noah M. |
| journal |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| journalStr |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
411 |
| author_browse |
Hahn, Noah M. |
| container_volume |
34 |
| physical |
7 |
| class |
610 610 DE-600 610 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Hahn, Noah M. |
| doi_str_mv |
10.1016/j.urolonc.2015.08.005 |
| dewey-full |
610 |
| title_sort |
neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| title_auth |
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| abstract |
Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). |
| abstractGer |
Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). |
| abstract_unstemmed |
Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC). |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
1 |
| title_short |
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity |
| url |
https://doi.org/10.1016/j.urolonc.2015.08.005 |
| remote_bool |
true |
| author2 |
Knudsen, Beatrice S. Daneshmand, Siamak Koch, Michael O. Bihrle, Richard Foster, Richard S. Gardner, Thomas A. Cheng, Liang Liu, Ziyue Breen, Timothy Fleming, Mark T. Lance, Raymond Corless, Christopher L. Alva, Ajjai S. Shen, Steven S. Huang, Fangjin Gertych, Arkadiusz Gallick, Gary E. Mallick, Jayati Ryan, Christopher Galsky, Matthew D. Lerner, Seth P. Posadas, Edwin M. Sonpavde, Guru |
| author2Str |
Knudsen, Beatrice S. Daneshmand, Siamak Koch, Michael O. Bihrle, Richard Foster, Richard S. Gardner, Thomas A. Cheng, Liang Liu, Ziyue Breen, Timothy Fleming, Mark T. Lance, Raymond Corless, Christopher L. Alva, Ajjai S. Shen, Steven S. Huang, Fangjin Gertych, Arkadiusz Gallick, Gary E. Mallick, Jayati Ryan, Christopher Galsky, Matthew D. Lerner, Seth P. Posadas, Edwin M. Sonpavde, Guru |
| ppnlink |
ELV012523860 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.urolonc.2015.08.005 |
| up_date |
2024-07-06T22:51:42.138Z |
| _version_ |
1803871901072752640 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02997285X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623203242.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.urolonc.2015.08.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02997285X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1078-1439(15)00402-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hahn, Noah M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Preclinical urothelial carcinoma models suggest activity of dasatinib, an oral SRC-family kinase (SFK) inhibitor. We sought to determine the feasibility and biologic activity of neoadjuvant dasatinib (Neo-D) in patients with muscle-invasive urothelial carcinoma of the bladder (miUCB) preceding radical cystectomy (RC).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Src-family kinases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neoadjuvant therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dasatinib</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Translational medical research</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bladder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelial carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Protein kinase inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Knudsen, Beatrice S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Daneshmand, Siamak</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koch, Michael O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bihrle, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Foster, Richard S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gardner, Thomas A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cheng, Liang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Ziyue</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Breen, Timothy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fleming, Mark T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lance, Raymond</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Corless, Christopher L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alva, Ajjai S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shen, Steven S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Fangjin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gertych, Arkadiusz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gallick, Gary E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mallick, Jayati</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ryan, Christopher</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galsky, Matthew D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lerner, Seth P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Posadas, Edwin M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sonpavde, Guru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Siero, Jeroen C.W. ELSEVIER</subfield><subfield code="t">BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex</subfield><subfield code="d">2014transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012523860</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:34</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:411-417</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.urolonc.2015.08.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">34</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">411-417</subfield><subfield code="g">7</subfield><subfield code="y">34.2016, 1, 4.e11-, (7 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.399419 |